Systems and Methods for Identifying HLA-associated Tumor Peptides
Copyright © Targeted News Service 2024
2024-11-05
ALEXANDRIA, Virginia, Nov. 5 -- REGENERON PHARMACEUTICALS, INC., Tarrytown, New York has been assigned a patent (No. US 12135327 B2, initially filed June 28, 2023) developed by Robert Salzler, Tarrytown, New York, for "Systems and methods for identifying HLA-associated tumor peptides." . . .